PA
MTG icon

PharVision Advisers’s MGIC Investment MTG Stock Holding History

PharVision Advisers’s Portfolio MTG Stock Details MTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,673
Closed -$218K – 894
2025
Q3 		$218K Sell
7,673
-1,533
-17% -$41.8K 0.12% 442
2025
Q2 		$256K Buy
+9,206
New +$237K 0.37% 125

Other funds holding MTG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

PharVision Advisers's MTG Position: Q4 2025 in Review

PharVision Advisers sold out of MGIC Investment (MTG) in Q4 2025, closing a stake of 7,673 shares — an estimated $218K sold.

PharVision Advisers first reported a position in MTG in Q2 2025 and held it in 2 quarters. The position peaked at $256K in Q2 2025. 526 funds tracked by Wall St. Rank hold MTG as of Q4 2025.

  • PharVision Advisers reported no remaining MGIC Investment position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 7,673 MGIC Investment shares in Q4 2025, an estimated $218K.
  • PharVision Advisers first reported a position in MGIC Investment in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's MGIC Investment position peaked at $256K in Q2 2025.
  • 526 funds tracked by Wall St. Rank held MGIC Investment as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.